BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 1063421)

  • 1. Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors.
    Aghajanian GK; Hailgler HJ
    Psychopharmacol Commun; 1975; 1(6):619-29. PubMed ID: 1063421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurophysiological effects of hallucinogens on serotonergic neuronal systems.
    McCall RB
    Neurosci Biobehav Rev; 1982; 6(4):509-14. PubMed ID: 7177511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve terminal effects of indoleamine psychotomimetics on 5-hydroxytryptamine.
    Halaris AE
    Neurosci Biobehav Rev; 1982; 6(4):483-7. PubMed ID: 6294571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of rat prolactin secretion by indolealkylamine hallucinogens.
    Meltzer HY; Fessler RG; Simonovic M; Fang VS
    Psychopharmacology (Berl); 1978 Apr; 56(3):255-9. PubMed ID: 148665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
    Trulson ME; Heym J; Jacobs BL
    Brain Res; 1981 Jun; 215(1-2):275-93. PubMed ID: 6114779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats.
    Trulson ME; Preussler DW; Trulson VM
    J Pharmacol Exp Ther; 1984 Jan; 228(1):94-102. PubMed ID: 6694110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
    Schoenfeld RI
    Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological aspects of hallucinogenic drugs.
    Logan WJ
    Adv Neurol; 1975; 13():47-78. PubMed ID: 814800
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative effects of hallucinogenic drugs on behavior of the cat.
    Jacobs BL; Trulson ME; Stark AD; Christoph GR
    Commun Psychopharmacol; 1977; 1(3):243-54. PubMed ID: 272265
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.
    Halberstadt AL; Koedood L; Powell SB; Geyer MA
    J Psychopharmacol; 2011 Nov; 25(11):1548-61. PubMed ID: 21148021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.
    Koerner J; Appel JB
    Psychopharmacology (Berl); 1982; 76(2):130-5. PubMed ID: 6805022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotomimetic drugs: biochemistry and pharmacology.
    Brimblecombe RW
    Adv Drug Res; 1973; 7():165-206. PubMed ID: 4613150
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiation of bufotenine-like syndrome induced by diethyltryptamine in reserpinized rats.
    Khazan N; Hirsch A; Sulman FG
    Electroencephalogr Clin Neurophysiol; 1967 Jun; 22(6):589. PubMed ID: 4165027
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of acute axotomy (spinal cord transection) on the turnover of 5-hydroxytryptamine.
    Andén NE
    Adv Biochem Psychopharmacol; 1974; 10():35-43. PubMed ID: 4276958
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: Excitatory and inhibitory monosynaptic actions mediated by a serotonin containing neurone in Aplysia californica.
    Gerschfeld HM; Paupardin-Tritsch D
    J Physiol; 1973 Oct; 234(2):28P-29P. PubMed ID: 4358350
    [No Abstract]   [Full Text] [Related]  

  • 16. Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex.
    Pierce PA; Peroutka SJ
    Psychopharmacology (Berl); 1989; 97(1):118-22. PubMed ID: 2540505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of 5-hydroxytryptamine and some related compounds on the cat superior cervical ganglion in situ.
    Haefely W
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 281(2):145-65. PubMed ID: 4361056
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory effects of lysergic acid derivatives and reserpine on 5-HT binding to nerve ending particles.
    Marchbanks RM
    Biochem Pharmacol; 1967 Oct; 16(10):1971-9. PubMed ID: 6065963
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of lysergic acid diethylamide and bufotenine on performance of trained rats.
    MAHLER DJ; HUMOLLER FL
    Proc Soc Exp Biol Med; 1959; 102():697-701. PubMed ID: 14419947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.